• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Improving stroke treatment with a modified therapeutic molecule

Bioengineer by Bioengineer
February 18, 2021
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A research team from INRS has improved the protective effect of a molecule against ischemic stroke

IMAGE

Credit: Christian Fleury (INRS)

A research team from the Institut national de la recherche scientifique (INRS) has improved the protective effect of a molecule against ischemic stroke, which is caused by an interruption of blood flow to the brain. The results of the study, conducted in collaboration with a Spanish team, were published in the Communications Biology of Nature Research journal.

Every year in Quebec, about 20,000 people have a stroke. Also known as a “cerebral infarction”, this sudden neurological deficit can lead to psychological and physical after-effects. These effects result from an increase in glutamate in the brain, which destroys neurons. “Glutamate is an essential neurotransmitter for neuronal communication, learning and memory processes, yet above a certain concentration, it becomes toxic to neuronal cells,” explains Ahlem Zaghmi, a newly graduated INRS doctoral student under the supervision of Professor Marc A. Gauthier.

The research team aimed at developing an effective treatment that would compensate for the increase in glutamate. What makes its approach unique? It works on the periphery. “Unlike other drugs, our molecule does not need to cross the blood-brain barrier to achieve its therapeutic effect. It represents one fewer obstacle, since it could be injected intravenously,” emphasizes the doctoral student.

The modified molecule, glutamate-oxaloacetate transaminase (GOT), is already known for its therapeutic effects. This enzyme breaks down the glutamate circulating in the bloodstream which creates a kind of siphon effect. “By decreasing concentrations of this neurotransmitter in the blood, excess glutamate in the brain will move out to compensate for the loss. This “siphons” the glutamate out of the brain,” she says.

A single dose of the molecule typically lasts three hours in rats. Due to the modification made by the research team, the treatment is now effective for six days! “Adding a polymer, polyethylene glycol, on the surface of the GOT enzyme increases its circulation time in the blood. The polymer will, among other things, protect the molecule from the immune system,” says Professor Gauthier, a specialist in bioorganic chemistry and biomaterials. “This has the advantage of maintaining the siphon effect over a period of time that exceeds the duration of the glutamate peak caused by the stroke in the brain, while reducing the number of doses given and the risk of side effects,” adds Ahlem Zaghmi.

The research team now intends to observe the longer-term effect of the molecule and explore applications to other neuronal diseases. Since glutamate toxicity is also associated with head trauma, Parkinson’s and Alzheimer’s disease, the research group could, among other things, test whether the modified molecule accelerates healing or, if so, slows the development of the disease.

###

About the study

The article “Sustained blood glutamate scavenging enhances protection in ischemic stroke”, by Ahlem Zaghmi, Antonio Dopico-López, María Pérez-Mato, Ramón Iglesias-Rey, Pablo Hervella, Andrea A. Greschner, Ana Bugallo-Casal, Andrés da Silva, María Gutiérrez-Fernández, José Castillo, Francisco Campos Pérez, and Marc A. Gauthier, was published in the Communications Biology of Nature Research journal. The study received financial support from the Natural Sciences and Engineering Research Council of Canada (NSERC), Mitacs, the Fonds de recherche du Québec – Nature et technologies (FRQNT) and the Fonds de recherche du Québec – Santé (FRQS), among others.

About INRS

INRS is a university dedicated exclusively to graduate level research and training. Since its creation in 1969, INRS has played an active role in Quebec’s economic, social, and cultural development and is ranked first for research intensity in Quebec and in Canada. INRS is made up of four interdisciplinary research and training centres in Quebec City, Montreal, Laval, and Varennes, with expertise in strategic sectors: Eau Terre Environnement, Énergie Matériaux Télécommunications, Urbanisation Culture Société, and Armand-Frappier Santé Biotechnologie. The INRS community includes more than 1,500 students, postdoctoral fellows, faculty members, and staff.

Source :

Audrey-Maude Vézina

Service des communications de l’INRS

418 254-2156

[email protected]

Media Contact
Audrey-Maude Vézina
[email protected]

Related Journal Article

http://dx.doi.org/10.1038/s42003-020-01406-1

Tags: BiochemistryBiomedical/Environmental/Chemical EngineeringChemistry/Physics/Materials SciencesneurobiologyNeurochemistryPharmaceutical SciencesPharmaceutical/Combinatorial ChemistryPolymer ChemistryStroke
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

CYBDOM Proteins Boost Plant Drought Resistance via Autophagy

August 1, 2025
blank

Metal Triggers Shape Shift in Sabiá Virus Spike

August 1, 2025

Global Upswing in Photosynthesis Driven by Land Counterbalanced by Oceans, New Study Finds

August 1, 2025

Supporting Me, Limiting You: Unraveling the Complex Interactions Within Intestinal Microbiota

August 1, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    37 shares
    Share 15 Tweet 9
  • Sustainability Accelerator Chooses 41 Promising Projects Poised for Rapid Scale-Up

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

CYBDOM Proteins Boost Plant Drought Resistance via Autophagy

Boosting Tumor Control: Radiation and ATR Inhibitor Trial

Neonatal Ultrasound: Training, Credentialing, and Quality Guidelines

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.